Radia Perlman has been designing network and routing protocols for a long time. In the early days, they were pretty fragile. It’s been Perlman’s work that’s made these protocols robust and scalable. She’s literally written the book on these topics, now in a 2nd edition.
It’s this perspective Perlman brings to “Blockchain,” which has been hyped as the biggest contribution to computing since the Internet.
It’s hard to define a buzzword like “Blockchain.” You could define it as something as vague and general as “a combination of computers networking,” which doesn’t make it any different from the computing we’ve been doing for decades.
Perlman simply defines “Blockchain” as data that’s arranged in chains of blocks. Every chain has a “hash,” which is especially difficult to compute.
It’s difficulty is its only security assumption. But how safe is that really? Find out in this podcast.
Gasoline gets a pretty low rating on the “green scale” and several companies like Uber and Lyft are helping to lessen its bad effects on our atmosphere.
But how does Filld, a company that specializes in personal gasoline delivery, get to tout the green benefits of their service?
Listen in as Christopher Aubuchon, the CTO of Filld explains.
Here’s a few things you’ll find out:
How the ecosystem behind Filld actually reduces the amount of gas we consume
How trained drivers and gas delivery employees are reducing fire hazards and eliminating spills caused from overfilling
The ins and outs of using Filld and a few insider tips on how to get the most from your tank of gasoline
How Filld is ramping up the meaning of full service
*If you love hearing the newest innovations in technology and how they’re changing our world, remember to subscribe and consider a bitcoin donation.
People don’t like to be sold—especially online. From spam filters to pop-up blockers, people do their best to stop unwanted advertisements from interrupting their virtual lives.
This creates a barrier between you as an entrepreneur or business owner and the online world you’d like to reach.
So, how can you get your brand’s message in front of teens, millennials and generation Zers who spend most of their time on a mobile device connected to the web?
That’s the question Christian Brucculeri, CEO of Snaps, answers for big brands everyday.
Listen in to hear how Snaps is changing the world of mobile online marketing.
Here’s a few things he shares:
How emoji’s can become brand building tools
How to legally hijack your customer’s iMessages and make them love you for it
How conversational media increases some brands awareness by 300%
If you’re loving this podcast, remember to subscribe and consider a bitcoin donation.
“You can do stupid things with electricity,” says Mike Weisend. Take poorly executed electroshock therapy for example. People end up literally frying their brains. It’s like being struck by lightening, and the therapeutic effects of being struck by lightening—if there any—have not been approved by the FDA. However, it’s undeniable that the brain is an electrical organ, and is effected by electricity. To better understand the cause and effect of electricity in the brain, Mike has been heading up research at RioGrandeNeuroScience, and developing therapies for illnesses are from depression to dementia.
“I’m a decent case study,” says Weisend. “I’ve zapped myself pretty frequently to test new paradigms, or electroconfigurations… or new technologies…. And… I’m doin’ alright. You know.”
Click play to listen to get the full scoop on non-invasive brain stimulation. As always, we hope you enjoy our content. Subscribe, review, and if you can, donate a BitCoin or two. Every little bit helps.
We’re living in an age where not only can DNA be synthesized, but it can be applied as a technology. The applications of DNA are manifold, and some, never-before-seen. TwistBioScience creates DNA that can be used to produce chemicals, store data, improve vaccines and therapeutics, and produce disease- and climate-resistant plants.
The thing about DNA is, the longer you get, the harder it is to make.
Twist makes DNA in short strands… about one millionth the length of the human genome: 3,200 base pairs. (When you’re making DNA with under 10,000 base pairs, you can use E. Coli, which is a well-understood, and well-behaved organism.
) These small genes can still be deployed, though; and in today’s market, that’s where the demand is.
Listen to learn more about making DNA from scratch.
Subscribe, review, and if you can, help keep us going by donating BitCoins. Every little bit helps.
Previously, the only way to see cells inside brain matter was to dissect a corpse’s brain and put it under a microscope.
Not so useful if you’re a brain disease patient seeking to stay alive. But, what if doctors could look at your living brain through a microscope without making a single incision?
That’s just what Brainvivo has made possible with brain imaging software that transforms MRI’s into virtual microscopes.
Listen in as Brainvivo’s co-founder Yaniv Assaf discusses some of the endless possibilities.
Here’s a sampling of what you’ll learn:
Why diagnosing Multiple Sclerosis takes 4 ½ years but it doesn’t have to anymore
How Brainvivo will cut down on misdiagnoses of brain disease
How this new imaging will help improve early treatment medications for Alzheimer’s and Multiple Sclerosis
*If you like what you’re hearing on “Almost Here: Round-the-Corner Future Technology,” please subscribe and donate bitcoins to keep us going.
Putting a man on the moon was amazing, but Andrew Rush, the CEO of Made In Space, is intent on helping humankind settle in space—not just camp there.
Listen in as he talks about how 3-D printing on the International Space Station is paving the way for men to survive and thrive in space as well as how we Earth dwellers will benefit from the industrial age of space.
Here’s a sampling of what you’ll discover:
How 3-D printing in space can keep astronauts safer and make space missions more affordable
The two biggest challenges of 3-D printing in zero gravity
What “Space Enabled” materials are and which one is set to make a paradigm shift in the future of telecommunications
*If you like what you’re hearing on “Almost Here: Round-the-Corner Future Technology,” please subscribe and donate bitcoins to keep us going.
Macular degeneration is the leading cause of blindness worldwide. This, especially in the aging population: you reach a certain age, and you can’t see as well as before. Up until this point, there has been no cure for macular degeneration. In the late stages of the illness, people are declared legally blind.
Enter BioTimeInc.
Francois Binette, head of product development, explains. “The cells that are keeping the photoreceptors healthy and happy are called the ‘retinal pigmented epithelial’ (RPE) cells.” With aging, or disease, these cells can degenerate. Without RPE cells, the eye can’t maintain its photoreceptors, and a person’s vision blurs and fades. “We have a very robust process of making these [RPE] cells,” explains Binette.
Listen now to find out how BioTimeInc. creates and employs RPE cells to cure blindness in aging adults.
Bio:
Dr. François Binette is Head of Global Development for Biotime Inc. Dr. Binette has over 20 years of experience driving innovation in regenerative medicine therapy development. During his first industry appointment at Genzyme Tissue Repair in Cambridge, he helped pioneer Carticel™ for cartilage repair, the first FDA BLA-approved cell therapy product for human use. He then led R&D for Biosyntech, a startup biomaterials company in Montreal applying its proprietary platform for various tissue engineering and drug delivery applications. His systematic approach to demonstrating proof of principle in various indications brought numerous corporate partnership deals helping Biosyntech through a public offering. Dr. Binette then joined the DePuy Franchise of Johnson and Johnson, the second largest orthopedic business worldwide. Dr. Binette led several innovative regenerative medicine combination product development initiatives from bench top to approved clinical trials in US and Europe. Following JNJ, Dr. Binette joined the Spinal and Biologics business unit of Medtronic, the world’s largest medical device company, developing biologics, active devices and combination products for interventional spine procedures for back pain. Dr Binette received his PhD from Laval University in Québec City, followed with post-doctoral training at the Sanford-Burnham institute in La Jolla, and Harvard Medical School in Boston.
When David Knight founded the data company terbine.com, he had big plans. “We’re not a broker, we’re not an analytics firm, we’re not an IOT platform,” says Knight. Instead, terbine.com was designed to be a global marketplace. Specifically, a marketplace for the data from the internet of things—the first of its kind.
“Not a modest charter,” Knight says. There are literally petabytes of data from the internet of things. And no one’s indexed it or made it machine- or human-searchable. Until now.
Fast approaching public beta, terbine.
com has had to start small in order to get big. As a friend of Knight’s put it, “Well, we wanna hear that you have the ambition to boil the oceans, but you need to start with boiling a teapot.” A successful prototype in a smaller market (the teapot) would determine the success of the later, finished platform (the oceans). Because of this, picking the right “teapot” was crucially important.
Hit play to hear the rest of terbine.com’s story, and learn more about the future of data in the internet of things.
